Saori Amiya

1.8k total citations
7 papers, 85 citations indexed

About

Saori Amiya is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Saori Amiya has authored 7 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Infectious Diseases and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Saori Amiya's work include Long-Term Effects of COVID-19 (1 paper), Tuberous Sclerosis Complex Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Saori Amiya is often cited by papers focused on Long-Term Effects of COVID-19 (1 paper), Tuberous Sclerosis Complex Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Saori Amiya collaborates with scholars based in Japan. Saori Amiya's co-authors include Atsushi Kumanogoh, Yoshito Takeda, Haruhiko Hirata, Takayuki Niitsu, Yoshimi Noda, Reina Hara, Kotaro Miyake, Takayuki Shiroyama, Yuichi Adachi and Takatoshi Enomoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and BMC Infectious Diseases.

In The Last Decade

Saori Amiya

7 papers receiving 85 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saori Amiya Japan 6 37 24 24 24 18 7 85
Reina Hara Japan 6 35 0.9× 24 1.0× 26 1.1× 37 1.5× 17 0.9× 12 96
Blerta Kertusha Italy 6 62 1.7× 16 0.7× 11 0.5× 21 0.9× 30 1.7× 13 123
S. Greffe France 5 36 1.0× 16 0.7× 9 0.4× 28 1.2× 8 0.4× 13 90
André Rebaza United States 5 70 1.9× 11 0.5× 15 0.6× 10 0.4× 37 2.1× 8 116
Silvia Rojo‐Rello Spain 6 70 1.9× 61 2.5× 15 0.6× 61 2.5× 30 1.7× 26 175
Thomas Hueso France 4 24 0.6× 21 0.9× 11 0.5× 11 0.5× 7 0.4× 10 108
Elena V. Shidlovskaya Russia 6 64 1.7× 22 0.9× 12 0.5× 19 0.8× 12 0.7× 13 89
Nadia D. Morgan United States 4 40 1.1× 14 0.6× 12 0.5× 12 0.5× 19 1.1× 4 112
Tamer Elhadidy Egypt 5 35 0.9× 13 0.5× 27 1.1× 5 0.2× 10 0.6× 15 95
Niklas Broman Finland 3 78 2.1× 19 0.8× 9 0.4× 17 0.7× 49 2.7× 5 106

Countries citing papers authored by Saori Amiya

Since Specialization
Citations

This map shows the geographic impact of Saori Amiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saori Amiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saori Amiya more than expected).

Fields of papers citing papers by Saori Amiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saori Amiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saori Amiya. The network helps show where Saori Amiya may publish in the future.

Co-authorship network of co-authors of Saori Amiya

This figure shows the co-authorship network connecting the top 25 collaborators of Saori Amiya. A scholar is included among the top collaborators of Saori Amiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saori Amiya. Saori Amiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Maeda, Yuichi, Daisuke Motooka, Takahiro Kawasaki, et al.. (2022). Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity. BMC Infectious Diseases. 22(1). 572–572. 28 indexed citations
2.
Noda, Yoshimi, Takayuki Shiroyama, Kentaro Masuhiro, et al.. (2022). Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer. Scientific Reports. 12(1). 8881–8881. 10 indexed citations
3.
Amiya, Saori, Kinnosuke Matsumoto, Makoto Yamamoto, et al.. (2022). Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination. International Journal of Infectious Diseases. 116. 255–257. 11 indexed citations
4.
Enomoto, Takatoshi, Takayuki Shiroyama, Haruhiko Hirata, et al.. (2022). COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier. SHILAP Revista de lepidopterología. 10(2). e05463–e05463. 10 indexed citations
5.
Noda, Yoshimi, Takayuki Shiroyama, Saori Amiya, et al.. (2021). COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation. Respiratory Medicine Case Reports. 34. 101505–101505. 2 indexed citations
6.
Amiya, Saori, Haruhiko Hirata, Takayuki Shiroyama, et al.. (2021). Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19. Respirology Case Reports. 9(7). e00801–e00801. 14 indexed citations
7.
Niitsu, Takayuki, Takayuki Shiroyama, Kotaro Miyake, et al.. (2020). Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review. Thoracic Cancer. 11(12). 3625–3630. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026